REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/31/2026
Back to search
Official data from USPTO
ONCOLOGY CARE VALUE PROGRAM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ONCOLOGY CARE VALUE PROGRAM
ST13
US500000086861930Class
35, 36
Filing
86861930
Registration
5134813
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
02/01/2026
Classification
Registered
Trademark type
Word
Nice classes
35, 36
Filing date
12/30/2015
Registration date
01/31/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/18/2023
Last transaction
02/01/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
12/15/2015
First use in commerce
12/15/2015
Drawing code
4
Owner type
03
Owner location
St. Louis, MO
Examiner
NEHMER, JASON ROBERT
Law office
N30
Current location
TMO LAW OFFICE 121
Holders and representatives
Holders
EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.
Express Scripts, Inc.
Representatives
Troy E. Larson Cigna Intellectual Property, Inc.
Technical classification
Nice Classes
Class 35Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Cost management for the health and prescription drug plans of others in the field of pharmaceuticalsclinical care and health care treatment; business servicesprescription drug formulary cost management services; consulting services regarding the costs of healthcare and pharmacy services
Class 36
Pharmacy benefit management consulting services; Pharmacy benefit management services
Publications
History of USPTO decisions and trademark events.
40 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/18/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/18/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/18/2023
ES8R
TEAS SECTION 8 RECEIVED
01/31/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/31/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/04/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/05/2017
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/31/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/28/2016
ALIE
ASSIGNED TO LIE
12/27/2016
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
12/09/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
12/08/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/08/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
12/08/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/08/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/30/2016
GNRT
NON-FINAL ACTION E-MAILED
11/30/2016
CNRT
NON-FINAL ACTION WRITTEN
11/30/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/11/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/11/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/11/2016
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
10/04/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/03/2016
GNRT
NON-FINAL ACTION E-MAILED
10/03/2016
IUAA
USE AMENDMENT ACCEPTED
10/03/2016
CNRT
NON-FINAL ACTION WRITTEN
10/03/2016
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
09/09/2016
IUAF
USE AMENDMENT FILED
09/09/2016
EAAU
TEAS AMENDMENT OF USE RECEIVED
09/08/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/09/2016
GNRT
NON-FINAL ACTION E-MAILED
03/09/2016
CNRT
NON-FINAL ACTION WRITTEN
03/09/2016
DOCK
ASSIGNED TO EXAMINER
03/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2016
NWAP
NEW APPLICATION ENTERED
01/02/2016
Continuous trademark protection
Get notified about every new filing that threatens ONCOLOGY CARE VALUE PROGRAM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.